Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQZNP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,928
Award facts
- Contract value 100% obligated
- $6,927.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for supply of ORGOVYX 120 MG tablets in quantities of 30s, valued at $6,927.60 with a firm fixed price structure and completion deadline of September 29, 2025. This delivery order represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates consistent capability to fulfill diverse pharmaceutical supply requirements through open competition, with delivery orders typically structured as firm fixed price contracts ranging from under $100 to over $45,000. This particular delivery order for ORGOVYX, a hormone treatment medication, reflects the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQZNP?
SPE2DB25FQZNP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FQZNP worth?
The government has obligated $6,928 on SPE2DB25FQZNP.
Is contract SPE2DB25FQZNP an order under another contract?
Yes. SPE2DB25FQZNP is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZNP competed?
The extent of competition for SPE2DB25FQZNP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award